The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concurrent GLP1R-agonist use with chemoimmunotherapy for early-stage triple-negative breast cancer.
 
Bethania Santos
No Relationships to Disclose
 
Ishrat Durdana
No Relationships to Disclose
 
Heather McArthur
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Merck; Moderna Therapeutics; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Felipe Dezem
No Relationships to Disclose
 
Hannah Chasteen
No Relationships to Disclose
 
Maycon Marção
No Relationships to Disclose
 
Jasmine Plummer
Employment - St. Jude Children's Research Hospital
Honoraria - UMiami Sylvester Comprehensive Cancer Center
 
Alexis LeVee
No Relationships to Disclose
 
Megan Wong
No Relationships to Disclose
 
Joanne Mortimer
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Pfizer
Research Funding - AstraZeneca
 
Joshua Gruber
Employment - Guardant Health (I)
Stock and Other Ownership Interests - Guardant Health (I)
Honoraria - bioTheranostics; Onviv
Consulting or Advisory Role - Sharma Therapeutics, LLC
Research Funding - Hummingbird (Inst)
Patents, Royalties, Other Intellectual Property - HAT1 inhibitor patents
(OPTIONAL) Uncompensated Relationships - Hummingbird